Literature DB >> 35940708

Food protein-derived bioactive peptides for the management of nutrition related chronic diseases.

Xinyi Cao1, Wang Liao2, Shaokang Wang1.   

Abstract

Dietary intervention via modifications of dietary pattern or supplementations of naturally derived bioactive compounds has been considered as an efficient approach in management of nutrition related chronic diseases. Food protein-derived bioactive peptide is representative of natural compounds which show the potential to prevent or mitigate nutrition related chronic diseases. In the past decades, substantial research has been conducted concentrating on the characterization, bioavailability, and activity assessment of bioactive peptides. Although various activities of bioactive peptides have been reported, the activity testes of most peptides were only conducted in cells and animal models. Some clinical trials of bioactive peptides were also reported but only limited to antihypertensive peptides, antidiabetic peptides and peptides modulating blood lipid profile. Hereby, clinical evidence of bioactive peptides in management of nutrition-related chronic diseases is summarized in this chapter, which aims at providing implications for the clinical studies of bioactive peptides in the future.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioactive peptides; Cardiovascular diseases; Clinical trial; Dietary supplementation; Metabolic diseases

Mesh:

Substances:

Year:  2022        PMID: 35940708     DOI: 10.1016/bs.afnr.2022.04.004

Source DB:  PubMed          Journal:  Adv Food Nutr Res        ISSN: 1043-4526


  1 in total

1.  Pea Protein-Derived Peptides Inhibit Hepatic Glucose Production via the Gluconeogenic Signaling in the AML-12 Cells.

Authors:  Wang Liao; Xinyi Cao; Hui Xia; Shaokang Wang; Guiju Sun
Journal:  Int J Environ Res Public Health       Date:  2022-08-18       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.